Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk

The Korean Transient Elastography Study Group

doi:10.1111/liv.15282

Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk

The Korean Transient Elastography Study Group

Department of Internal Medicine

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1902-1906
Number of pages	5
Journal	Liver International
Volume	42
Issue number	8
DOIs	https://doi.org/10.1111/liv.15282
Publication status	Published - 2022 Aug

Bibliographical note

Funding Information:
This study was supported by the Technology Innovation Program (20013712) funded by the Ministry of Trade, Industry, and Energy (MOTIE, Korea). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Hepatology

Access to Document

10.1111/liv.15282

Cite this

@article{a2812afcd8ab4adb82567997949e4b8d,

title = "Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk",

author = "\{The Korean Transient Elastography Study Group\} and Kim, \{David Sooik\} and Kim, \{Beom Kyung\} and Seo, \{Yeon Seok\} and Kim, \{Byung Seok\} and Jang, \{Byoung Kuk\} and Kim, \{Sang Gyune\} and Suk, \{Ki Tae\} and Lee, \{Jin Woo\} and Jeong, \{Soung Won\} and Kim, \{Seung Up\}",

note = "Funding Information: This study was supported by the Technology Innovation Program (20013712) funded by the Ministry of Trade, Industry, and Energy (MOTIE, Korea). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. ",

year = "2022",

month = aug,

doi = "10.1111/liv.15282",

language = "English",

volume = "42",

pages = "1902--1906",

journal = "Liver International",

issn = "1478-3223",

publisher = "Wiley-Blackwell",

number = "8",

}

TY - JOUR

T1 - Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk

AU - The Korean Transient Elastography Study Group

AU - Kim, David Sooik

AU - Kim, Beom Kyung

AU - Seo, Yeon Seok

AU - Kim, Byung Seok

AU - Jang, Byoung Kuk

AU - Kim, Sang Gyune

AU - Suk, Ki Tae

AU - Lee, Jin Woo

AU - Jeong, Soung Won

AU - Kim, Seung Up

N1 - Funding Information: This study was supported by the Technology Innovation Program (20013712) funded by the Ministry of Trade, Industry, and Energy (MOTIE, Korea). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

PY - 2022/8

Y1 - 2022/8

UR - https://www.scopus.com/pages/publications/85131539651

UR - https://www.scopus.com/pages/publications/85131539651#tab=citedBy

U2 - 10.1111/liv.15282

DO - 10.1111/liv.15282

M3 - Letter

C2 - 35474279

AN - SCOPUS:85131539651

SN - 1478-3223

VL - 42

SP - 1902

EP - 1906

JO - Liver International

JF - Liver International

IS - 8

ER -

Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk

Bibliographical note

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this